Issue 47, 2016

A novel PEG–haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer–drug conjugates in a non-prodrug fashion

Abstract

A PEG–haloperidol conjugate containing a non-biodegradable linker was synthesised. Incubation with rat plasma demonstrated excellent linker stability, and competition radioligand binding assays demonstrated retained binding to the D2-receptor. In silico studies predicted that the conjugate will not cross the blood–brain barrier (BBB), thus potentially restricting haloperidol action to one side of the BBB.

Graphical abstract: A novel PEG–haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer–drug conjugates in a non-prodrug fashion

Article information

Article type
Communication
Submitted
15 Aug 2016
Accepted
21 Oct 2016
First published
15 Nov 2016
This article is Open Access
Creative Commons BY license

Polym. Chem., 2016,7, 7204-7210

A novel PEG–haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer–drug conjugates in a non-prodrug fashion

F. Heath, A. Newman, C. Clementi, G. Pasut, H. Lin, G. J. Stephens, B. J. Whalley, H. M. I. Osborn and F. Greco, Polym. Chem., 2016, 7, 7204 DOI: 10.1039/C6PY01418F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements